Log in to save to my catalogue

Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopath...

Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopath...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2314307837

Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopathy

About this item

Full title

Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopathy

Publisher

United States: Public Library of Science

Journal title

PloS one, 2019-11, Vol.14 (11), p.e0224467-e0224467

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Nemaline myopathy (NEM) is a congenital neuromuscular disorder primarily caused by nebulin gene (NEB) mutations. NEM is characterized by muscle weakness for which currently no treatments exist. In NEM patients a predominance of type I fibers has been found. Thus, therapeutic options targeting type I fibers could be highly beneficial for NEM patient...

Alternative Titles

Full title

Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2314307837

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2314307837

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0224467

How to access this item